Observational study of wound care treatments to track wound healing and safety in everyday practice

You may qualify if

• Subject is male or female ≥18 years of age.
• Subject has an ulcer (Diabetic foot ulcer, Venous stasis ulcer, etc.), injury (trauma, post -surgical, MOHS treatment), Burns injury, and/or other acute/chronic wounds.
• Subject has clinical documentation of no visible wound improvement in the wound after 4 weeks of standard of care therapy.
• Study wound is a minimum of 1 cm2 at Visit 1.
• The subject is able and willing to follow the protocol requirements.
• The subject has signed the informed consent form.
• Subject has adequate circulation to the affected extremity. Note: This will be confirmed by vascular perfusion assessment performed prior to enrollment, if clinically indicated per Institutional standard of care.

You can't join if

• Subject has a known life expectancy < 1 year.
• Subject has major uncontrolled medical disorders such as serious cardiovascular, renal, liver, or pulmonary disease, lupus, palliative care or sickle cell anemia.
• Subject currently being treated for an active malignant disease or subjects with a history of malignancy within the wound.
• Known contraindications to advance therapy tissues or products.
• Subjects with a history of more than two weeks treatment with immunosuppressants (including systemic corticosteroids >10 mg daily dose), cytotoxic chemotherapy, or application of topical steroids to the wound surface within one month prior to Visit 1.
• Affected extremity requiring hyperbaric oxygen during the study or within 2 weeks of Visit 1.
• Known HbA1c >12%.
• Subjects who are pregnant or breastfeeding.